During the last session, ProKidney Corp (NASDAQ:PROK)’s traded shares were 0.39 million, with the beta value of the company hitting 1.45. The 52-week high for the PROK share is $4.28, that puts it down -494.44 from that peak though still a striking 36.11% gain since the share price plummeted to a 52-week low of $0.46. The company’s market capitalization is $211.56M, and the average trade volume was 843.67K shares over the past three months.
ProKidney Corp (PROK) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.20. PROK has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.15.
ProKidney Corp (NASDAQ:PROK) trade information
ProKidney Corp (PROK) registered a 0.32% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.32% in intraday trading to $0.72, hitting a weekly high. The stock’s 5-day price performance is -1.91%, and it has moved by -18.38% in 30 days. Based on these gigs, the overall price performance for the year is -80.52%.
The consensus price target of analysts on Wall Street is $5, which implies an increase of 85.6% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3 and $6 respectively. As a result, PROK is trading at a discount of -733.33% off the target high and -316.67% off the low.
ProKidney Corp (PROK) estimates and forecasts
In the rating firms’ projections, revenue will increase 126.97% compared to the previous financial year.
While earnings are projected to return 9.74% in 2025, the next five years will return -2.31% per annum.
PROK Dividends
ProKidney Corp is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 9.34 million shares, is of SUVRETTA CAPITAL MANAGEMENT, LLC’s that is approximately 12.306% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $22.98 million.
Also, the Mutual Funds coming in first place with the largest holdings of ProKidney Corp (PROK) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 2.97 shares. This amounts to just over 2.29 percent of the company’s overall shares, with a $2.15 million market value. The same data shows that the other fund manager holds slightly less at 2.75, or about 2.13% of the stock, which is worth about $1.99 million.
